Ltea Biopharma Ltd.

Lutea Biopharmaceuticals Ltd. is specialized in development of novel therapeutics for cancer and inflammatory diseases. Our drug candidates – the NUP, target a cellular protein NF-κB (nuclear factor kappa – B cells), Lutea’s NUP has been investigated for years and was found to be effective in suppressing cancer cells in vitro (Hodgkin’s lymphoma and breastContinue reading “Ltea Biopharma Ltd.”